Literature DB >> 32295999

The First Case of TEMPI Syndrome in Japan.

Tatsunori Shizuku1, Keiji Matsui1, Shinya Yagi2, Shogo Iwabuchi1.   

Abstract

TEMPI syndrome, a disease entity comprising telangiectasia, erythrocytosis with high erythropoietin, monoclonal gammopathy, perinephric fluid collection, and intrapulmonary shunting, was first described by Sykes et al. in 2011. To our knowledge, only 15 cases have been reported worldwide, none of which were in Japan. We herein report a 47-year-old man who had intractable ascites for 2 and a half years and was referred to our department for a peritoneovenous shunt. In addition to ascites, he had telangiectasia, high erythropoietin, monoclonal gammopathy, and perinephric fluid collection. Thus, this is the first case of TEMPI syndrome in Japan.

Entities:  

Keywords:  TEMPI syndrome; erythrocytosis; monoclonal gammopathy; perinephric fluid collection

Year:  2020        PMID: 32295999     DOI: 10.2169/internalmedicine.3547-19

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

Review 1.  TEMPI Syndrome: Update on Clinical Features, Management, and Pathogenesis.

Authors:  Jian Xu; Wenqi Liu; Fengjuan Fan; Bo Zhang; Fei Zhao; Yu Hu; Chunyan Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-19       Impact factor: 6.055

2.  Case Report: TEMPI syndrome: Report of three cases and treatment follow-up.

Authors:  Zhuo-Fan Xu; Jing Ruan; Long Chang; Sijin Wu; Jinkai Lin; Wei Wang; XinXin Cao; Lu Zhang; Jian Li; Daobin Zhou; Wei Zhang
Journal:  Front Oncol       Date:  2022-08-03       Impact factor: 5.738

3.  Whole-genome sequencing suggests a role of MIF in the pathophysiology of TEMPI syndrome.

Authors:  Chunyan Sun; Jian Xu; Bo Zhang; Haifan Huang; Lei Chen; Han Yan; Aoshuang Xu; Fei Zhao; Daijuan Huang; Liqiong Liu; Jian Li; Yu Hu
Journal:  Blood Adv       Date:  2021-06-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.